Researchers within Penn Rheumatology investigate the clinical, translational and basic science aspects of autoimmunity and the rheumatic diseases. Penn Rheumatology investigators are currently studying vasculitis, lupus, scleroderma, Sjogren's syndrome, rheumatoid arthritis, psoriatic arthritis, gout, viral-associated inflammatory diseases, basic T- and B-cell biology, autoimmunity and more. In addition, Penn Rheumatology has developed focused centers for research and patient care in scleroderma, vasculitis, lupus, Sjögren's syndrome, and psoriatic arthritis.
The academic environment at Penn is truly exceptional, providing rheumatology investigators access to a wealth of resources to conduct high quality research. Furthermore, given the multidisciplinary nature of these diseases, our investigators have numerous collaborations locally, nationally and internationally.
Penn Rheumatology is committed to developing leaders in rheumatology research through the training of postdoctoral research fellows and through directed research rotations/experiences for medical students and residents. Fellows often take part in one of the Perelman School of Medicine's Master's or certificate programs.
Penn Rheumatology Investigators
- Josh Baker, MD, MSCE
- Chris Derk, MD, MSC
- Terri Laufer, MD
- Bruce Freundlich, MD
- Peter Merkel, MD, MPH
- Alexis Ogdie-Beatty, MD, MSCE
- Nora Sandorfi, MD